The major goals for professor David Communi are to decipher molecular mechanisms implicated in cellular signalling, as well as to discover novel clinical biomarkers, by using structural and quantitative proteomics (and metabolomics) for various neurological or systemic pathologies, such as multiple sclerosis, acute brain injury, encephalitis and idiopathic pulmonary fibrosis. It represents a mandatory step to improve precision medicine for diagnosis, prognosis and therapeutic follow-up. Moreover, the discovery of novel biomarkers will also provide new insights in the understanding of the molecular mechanisms of diseases.
Academic Proteomics and Clinical Research Center
To identify and quantify proteins and metabolites for fundamental as well as clinical research, and thereby find novel mechanistic and diagnostic biomolecules related to cellular signalling and to pathologies
Untargeted and targeted proteomics, SWATH® Acquisition quantification